Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation

Bioorg Med Chem Lett. 2009 Nov 1;19(21):6148-56. doi: 10.1016/j.bmcl.2009.09.017. Epub 2009 Sep 10.

Abstract

Piperazinyl-glutamate-pyrimidines were prepared with oxygen, nitrogen, and sulfur substitution at the 4-position of the pyrimidine leading to highly potent P2Y12 antagonists. In particular, 4-substituted piperidine-4-pyrimidines provided compounds with exceptional potency. Pharmacokinetic and physicochemical properties were fine-tuned through modifications at the 4-position of the piperidine ring leading to compounds with good human PRP potency, selectivity, clearance and oral bioavailability.

MeSH terms

  • Animals
  • Fibrinolytic Agents / chemical synthesis
  • Fibrinolytic Agents / chemistry*
  • Fibrinolytic Agents / pharmacokinetics
  • Glutamic Acid / chemistry*
  • Humans
  • Male
  • Piperidines / chemistry*
  • Platelet Aggregation / drug effects*
  • Purinergic P2 Receptor Antagonists*
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry*
  • Pyrimidines / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2Y12
  • Structure-Activity Relationship

Substances

  • Fibrinolytic Agents
  • P2RY12 protein, human
  • Piperidines
  • Purinergic P2 Receptor Antagonists
  • Pyrimidines
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y12
  • Glutamic Acid
  • piperidine